Journal Basic Info
- Impact Factor: 1.995**
- H-Index: 8
- ISSN: 2474-1647
- DOI: 10.25107/2474-1647
Major Scope
- Cardiovascular Surgery
- General Surgery
- Otolaryngology - Head and Neck Surgery
- Plastic Surgery
- Endocrine Surgery
- Oral and Maxillofacial Surgery
- Surgical Oncology
- Pediatric Surgery
Abstract
Citation: Clin Surg. 2018;3(1):2177.Case Report | Open Access
Aortic Dissection and Direct Factor Xa Inhibitors: Uncharted Waters
Igo B Ribeiro, Sean Dickie, Donna Nicholson, Pietro Di Santo and Marc Ruel
Department of Cardiac Surgery, University of Ottawa Heart Institute, Canada
Department of Cardiac Anesthesia, University of Ottawa Heart Institute, Canada
Department of Cardiology, University of Ottawa Heart Institute, Canada
PDF Full Text DOI: 10.25107/2474-1647.2177
Abstract
Acute type A aortic dissection is a surgical emergency due to the high mortality in medically treated patients mainly in the first 48 hrs of presentation. The use of factor Xa inhibitors in patients presenting with acute aortic dissection is a challenging situation. Surgical delay has been proposed to mitigate extensive surgical bleeding. We present a case of a patient on Rivaroxaban who could not tolerate delayed surgery and developed massive bleeding despite the use of thromboelastography and specific anti-Xa essay to guide optimal surgical time.
Keywords
Aortic dissection; DOAC; Factor Xa Inhibitors
Cite the article
Ribeiro IB, Dickie S, Nicholson D, Di Santo P, Ruel M. Aortic Dissection and Direct Factor Xa Inhibitors: Uncharted Waters. Clin Surg. 2018; 3: 2177.
